JPRN-UMIN000046650招募中未知
exploratory study of optimizing ustekinumab dosing interval in ulcerative colitis - exploratory study of optimizing ustekinumab dosing interval in ulcerative colitis
JUNTENDO UNIVERSITY NERIMA HOSPITA0 个研究点目标入组 30 人开始时间: 2022年1月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients judged by the principal investigator to be inappropriate as subjects 2.Patients without discernment 3.Patients who cannot obtain written consent
研究者
相似试验
招募中
4 期
Prospective follow-up study of ustekinumab treatment in psoriatic arthritisrheumatic disease10023213psoriatic arthritisNL-OMON40967Jan van Breemen Instituut50
进行中（未招募）
1 期
A study meausring ustekinumab concentrations through dried blood spot sampling in Crohn’s disease patientsCrohn's diseaseEUCTR2019-002038-35-BEZ Leuven30
招募中
不适用
Prospective evaluation of ustekinumab(UST)- effects in patients with ulcerative colitisulcerative colitisJPRN-UMIN000039946Saitama Medical Ctnter, Saitama Medical University35
已完成
2 期
A Study of Ustekinumab (STELARA®) in Adult Japanese Participants With Severe Atopic DermatitisDermatitis, AtopicNCT01945086Janssen Pharmaceutical K.K.79
已完成
1 期
A Pharmacokinetic Study of Ustekinumab in Pediatric Subjects With Moderately to Severely Active Crohn's DiseaseCrohn DiseaseNCT02968108Janssen Research & Development, LLC45